Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseEarly Phase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ RecruitingEarly Phase 1 A Phase 1 Randomized, Placebo-Controlled, Blinded Study Evaluating the Safety, Tolerability, and Pharmacokinetics of ARC-001 in Participants Undergoing Third Molar Extraction
The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are:
1. How much of the investigational product is absorbed in the blood?
2. Are there side effects?
100 Clinical Results associated with Arcato Laboratories, Inc.
0 Patents (Medical) associated with Arcato Laboratories, Inc.
100 Deals associated with Arcato Laboratories, Inc.
100 Translational Medicine associated with Arcato Laboratories, Inc.